A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...

Omada Health is making its public-market debut, propelled by Americans’ renewed focus on how weight affects physical health.

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

GLP-1 drugs alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even ...

As consumers taking medications like Ozempic cut back on eating out, about 70% are spending more on cooking at home, ...

Another challenge is brewing for restaurants. It’s not the economy, another global disease, or a weather disaster. It’s the ...

A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

We are just starting to learn more about the systemic impact of these medications,” Dr. Shiara Ortiz-Pujols told The Post.

HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...

Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...